These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37857130)

  • 21. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
    Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
    Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors.
    Mabey B; Hughes E; Kucera M; Simmons T; Hullinger B; Pederson HJ; Yehia L; Eng C; Garber J; Gary M; Gordon O; Klemp JR; Mukherjee S; Vijai J; Offit K; Olopade OI; Pruthi S; Kurian A; Robson ME; Whitworth PW; Pal T; Ratzel S; Wagner S; Lanchbury JS; Taber KJ; Slavin TP; Gutin A
    Genet Med; 2024 Jul; 26(7):101128. PubMed ID: 38829299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program.
    Wright SJ; Eden M; Ruane H; Byers H; Evans DG; Harvie M; Howell SJ; Howell A; French D; Payne K
    MDM Policy Pract; 2023; 8(1):23814683231171363. PubMed ID: 37152662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
    van Veen EM; Brentnall AR; Byers H; Harkness EF; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
    JAMA Oncol; 2018 Apr; 4(4):476-482. PubMed ID: 29346471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
    Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
    Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polygenic Breast Cancer Risk for Women Veterans in the Million Veteran Program.
    Minnier J; Rajeevan N; Gao L; Park B; Pyarajan S; Spellman P; Haskell SG; Brandt CA; Luoh SW
    JCO Precis Oncol; 2021 Jul; 5():. PubMed ID: 34381935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire.
    Vianna FSL; Giacomazzi J; Oliveira Netto CB; Nunes LN; Caleffi M; Ashton-Prolla P; Camey SA
    Genet Mol Biol; 2019; 42(1 suppl 1):232-237. PubMed ID: 31170278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.
    Läll K; Lepamets M; Palover M; Esko T; Metspalu A; Tõnisson N; Padrik P; Mägi R; Fischer K
    BMC Cancer; 2019 Jun; 19(1):557. PubMed ID: 31182048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Analysis between the Gail, Tyrer-Cuzick and BRCAPRO Models for Breast Cancer Screening in Brazilian Population.
    Stevanato KP; Pedroso RB; Iora P; Santos LD; Pelloso FC; Melo WA; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3407-3413. PubMed ID: 31759366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.
    Amir E; Evans DG; Shenton A; Lalloo F; Moran A; Boggis C; Wilson M; Howell A
    J Med Genet; 2003 Nov; 40(11):807-14. PubMed ID: 14627668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study.
    Glynn RJ; Colditz GA; Tamimi RM; Chen WY; Hankinson SE; Willett WW; Rosner B
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1187-1194. PubMed ID: 31015199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of a Cross-Ancestry Polygenic Model With Clinical Risk Factors Improves Breast Cancer Risk Stratification.
    Tshiaba PT; Ratman DK; Sun JM; Tunstall TS; Levy B; Shah PS; Weitzel JN; Rabinowitz M; Kumar A; Im KM
    JCO Precis Oncol; 2023 Feb; 7():e2200447. PubMed ID: 36809055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
    Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
    BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.
    Cuzick J; Brentnall AR; Segal C; Byers H; Reuter C; Detre S; Lopez-Knowles E; Sestak I; Howell A; Powles TJ; Newman WG; Dowsett M
    J Clin Oncol; 2017 Mar; 35(7):743-750. PubMed ID: 28029312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in Breast Cancer Risk Model Estimates Among Women in Their 40s Seen in Primary Care.
    Schonberg MA; Karamourtopoulos M; Pinheiro A; Davis RB; Sternberg SB; Mehta TS; Gilliam EA; Tung NM
    J Womens Health (Larchmt); 2022 Apr; 31(4):495-502. PubMed ID: 35073183
    [No Abstract]   [Full Text] [Related]  

  • 36. Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis.
    Holm J; Li J; Darabi H; Eklund M; Eriksson M; Humphreys K; Hall P; Czene K
    J Clin Oncol; 2016 Jan; 34(3):251-8. PubMed ID: 26628467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort.
    Lakeman IMM; Rodríguez-Girondo M; Lee A; Ruiter R; Stricker BH; Wijnant SRA; Kavousi M; Antoniou AC; Schmidt MK; Uitterlinden AG; van Rooij J; Devilee P
    Genet Med; 2020 Nov; 22(11):1803-1811. PubMed ID: 32624571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-
    Lakeman IMM; Hilbers FS; Rodríguez-Girondo M; Lee A; Vreeswijk MPG; Hollestelle A; Seynaeve C; Meijers-Heijboer H; Oosterwijk JC; Hoogerbrugge N; Olah E; Vasen HFA; van Asperen CJ; Devilee P
    J Med Genet; 2019 Sep; 56(9):581-589. PubMed ID: 31186341
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.